Rasagiline-13C3 mesylate (racemic) is a highly potent, selective, and irreversible inhibitor of mitochondrial monoamine oxidase (MAO), with IC50 values of 4.43 nM and 412 nM for rat brain MAO-B and MAO-A activity, respectively; used in vitro as a racemic mixture for studying MAO inhibition.